<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04648306</url>
  </required_header>
  <id_info>
    <org_study_id>V1-07012019</org_study_id>
    <nct_id>NCT04648306</nct_id>
  </id_info>
  <brief_title>Restore EF Observational Study</brief_title>
  <official_title>Restore EF Observational Study (in High-risk PCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abiomed Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abiomed Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center, prospective, observational, non-interventional single arm, study of the&#xD;
      intermediate-term clinical outcomes collected from electronic health records of high-risk&#xD;
      patients which have previously undergone standard of care prophylactic Impella support for a&#xD;
      non-emergent percutaneous coronary intervention (PCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Hypothesis The prophylactic use of Impella 2.5 or CP heart pumps during a non-emergent&#xD;
           PCI in hemodynamically stable patients at high-risk for periprocedural complications&#xD;
           during the procedure is associated with a significant improvement in the patient's LVEF&#xD;
           and clinical status (heart failure symptoms and hospital readmissions) in the&#xD;
           intermediate-term follow-up period post-ProPCI&#xD;
&#xD;
        2. Objectives The primary objective of this study is to assess the patient's LVEF at 90&#xD;
           days post-ProPCI (60 to 180 days window) as assessed in routine clinical practice and&#xD;
           collected from EHR by clinical investigators.&#xD;
&#xD;
           The secondary objective of the study is to assess the potential association between the&#xD;
           completeness of revascularization and the clinical status at 90 days post-ProPCI (60-180&#xD;
           days window). Clinical status includes NYHA heart failure functional class and hospital&#xD;
           readmission.&#xD;
&#xD;
        3. Sample Size: The study will enroll more than 1,000 patients at up to 30 investigational&#xD;
           sites with experienced Impella operators (≥ 25 cases).&#xD;
&#xD;
        4. Primary Endpoint: Subject's LVEF at 90 days post-ProPCI (60 to 180 days window)&#xD;
           collected from the subject's EHR.&#xD;
&#xD;
        5. Secondary Endpoints:&#xD;
&#xD;
             -  Completeness and extent of revascularization&#xD;
&#xD;
             -  NYHA functional class at 90 days post-ProPCI (60 to 180 days window)&#xD;
&#xD;
             -  Readmission at 90 days post-ProPCI (60 to 180 days window)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>Left ventricular ejection fraction (LVEF)</measure>
    <time_frame>90 days post Protective PCI (60 to 180 days window)</time_frame>
    <description>Left ventricular ejection fraction (LVEF) %</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival Rate</measure>
    <time_frame>90 days post Protected PCI (60 to 180 days window)</time_frame>
    <description>Survival rate post non-emergent percutaneous coronary intervention (ProPCI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA Functional Class</measure>
    <time_frame>90 days post Protected PCI (60 to 180 days window)</time_frame>
    <description>New York Heart Association (NYHA) functional class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>90 days post Protected PCI (60 to 180 days window)</time_frame>
    <description>Readmission post non-emergent percutaneous coronary intervention (ProPCI)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">406</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Unstable Angina</condition>
  <condition>Angina, Stable</condition>
  <condition>NSTEMI - Non-ST Segment Elevation MI</condition>
  <arm_group>
    <arm_group_label>Impella cohort</arm_group_label>
    <description>Single arm study of patients who underwent non-emergent percutaneous coronary intervention with prophylactic Impella support</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prophylactic Impella support for a non-emergent PCI</intervention_name>
    <description>Impella percutaneous mechanical circulatory support is placed via the femoral or axillary artery prior to a non-emergent PCI in patients at high risk for periprocedural complications including hemodynamic collapse.</description>
    <arm_group_label>Impella cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who meet all the inclusion criteria and none of the exclusion criteria will be&#xD;
        enrolled in the study.&#xD;
&#xD;
        Patients in whom prophylactic hemodynamic support with Impella was used during a&#xD;
        non-emergent PCI will be evaluated for study participation at 60 days post index PCI&#xD;
        procedure with Impella. In this study the index procedure is designated as Impella&#xD;
        Protected PCI (ProPCI). Patients with cardiogenic shock and/or ST elevation myocardial&#xD;
        infarction (STEMI) at the time of Impella initiation will not be included in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Subject has previously undergone (≥ 60 days) an Impella Protected PCI (ProPCI) at a&#xD;
             study site as identified in the Impella quality (IQ) assurance database (patients who&#xD;
             expired or were lost to follow-up prior to opening of the follow-up study window (day&#xD;
             60 post Impella protected PCI) will not be included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject with cardiogenic shock at the time of Impella insertion. Cardiogenic shock&#xD;
             defined as: systemic hypotension (systolic blood pressure (SBP) &lt;90 mmHg or the need&#xD;
             for inotropes/pressors to maintain a SBP &gt;90mmHg)&#xD;
&#xD;
          -  Subject with ST elevation myocardial infarction at the time of Impella insertion.&#xD;
&#xD;
          -  Subject underwent coronary bypass surgery after the index Impella ProPCI&#xD;
&#xD;
          -  Subject underwent repeat revascularization with PCI after the index Impella ProPCI&#xD;
&#xD;
          -  Subject underwent other cardiac procedures including valve therapies (surgical or&#xD;
             percutaneous) after the index Impella ProPCI&#xD;
&#xD;
          -  Subject underwent cardiac resynchronization therapy (CRT) initiated after the index&#xD;
             Impella ProPCI&#xD;
&#xD;
          -  Any known medical condition with a life expectancy &lt;6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thom Dahle, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Saint Cloud Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jason Wollmuth, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Providence Health &amp; Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lynn Morris, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Vidant Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Craig Thompson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>NYU Langone</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Joseph's Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Regional Medical Center</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Cardiology P.A.</name>
      <address>
        <city>North Little Rock</city>
        <state>Arkansas</state>
        <zip>72117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Medical Center</name>
      <address>
        <city>Springdale</city>
        <state>Arkansas</state>
        <zip>72764</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advent Health</name>
      <address>
        <city>Daytona Beach</city>
        <state>Florida</state>
        <zip>32117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60076</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis Medical Center</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Healthcare System</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lafayette General Medical Center</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>28275</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presbyterian Hospital Dallas</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingwood Medical Center</name>
      <address>
        <city>Kingwood</city>
        <state>Texas</state>
        <zip>77339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Healthcare</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>November 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Impella</keyword>
  <keyword>Hemodynamic Mechanical Support</keyword>
  <keyword>Left ventricular ejection fraction</keyword>
  <keyword>Surgical turndown</keyword>
  <keyword>High Risk PCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

